Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emran Askari

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Clinical Nuclear Medicine|May 11, 2026
Response Assessment of Gastric Adenocarcinoma Using ⁶⁸Ga-FAPI-46 and 18F-FDG PET/CT: Highlighting the Role of the Tumor Microenvironment in Therapy ResistanceMahsa Sheikhnezami, Mohammad Hadi Samadi, Ramin Sadeghi, et al.
Clinical Nuclear Medicine|May 18, 2026
99mTc-FAPI-46 Scintigraphy in Parotid Mucoepidermoid CarcinomaAmin Saber Tanha, Kamran Aryana, Siavash Zahed Anaraki, et al.
Clinical Nuclear Medicine|July 1, 2025
Detection of Peritoneal Carcinomatosis in Prostate Cancer via 99mTc-HYNIC-PSMA-11 ScintigraphyNasrin Raeisi, Amin Saber Tanha, Atena Aghaee, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 2, 2024
Eye-Related Adverse Events After I-131 Radioiodine Therapy: A Systematic Review of the Current LiteratureElham Rahmanipour, Emran Askari, Mohammad Ghorbani, et al.
Clinical Genitourinary Cancer|January 31, 2026
Treatment Discontinuation in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Lutetium-177 (<sup>177</sup>Lu)-PSMA-617: A Retrospective Real-World StudyMohammad Hadi Samadi, Amirreza Shamshirgaran, Pegah Sahafi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|November 19, 2024
Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failuresNarjess Ayati, Emran Askari, Maryam Fotouhi, et al.
Clinical Nuclear Medicine|April 20, 2026
Exceptional Response to Short-course 177Lu-PSMA Radioligand Therapy in a Patient With Metastatic Hormone-sensitive Prostate CancerNikoo Rezaei Borujerdi, Amin Saber Tanha, Haniye Elahifard, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 13, 2023
The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid CancerFarnaz Nesari Javan, Emran Askari, Susan Shafiei, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|June 16, 2023
How did the COVID-19 pandemic affect the referral patterns for SPECT myocardial perfusion? A single center experienceSaeedeh Ataei Nakhaei, Emran Askari, Hadis Mohammadzadeh, et al.
Nuklearmedizin. Nuclear Medicine|July 10, 2024
Comparison of 8th and 7th editions of TNM staging in terms of mortality, persistent disease, and response to treatment in patients with differentiated thyroid cancerGolnaz Gholami, Atena Aghaee, Susan Shafiei, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Clinical Nuclear Medicine|May 11, 2026
Response Assessment of Gastric Adenocarcinoma Using ⁶⁸Ga-FAPI-46 and 18F-FDG PET/CT: Highlighting the Role of the Tumor Microenvironment in Therapy ResistanceMahsa Sheikhnezami, Mohammad Hadi Samadi, Ramin Sadeghi, et al.
Clinical Nuclear Medicine|May 18, 2026
99mTc-FAPI-46 Scintigraphy in Parotid Mucoepidermoid CarcinomaAmin Saber Tanha, Kamran Aryana, Siavash Zahed Anaraki, et al.
Clinical Nuclear Medicine|July 1, 2025
Detection of Peritoneal Carcinomatosis in Prostate Cancer via 99mTc-HYNIC-PSMA-11 ScintigraphyNasrin Raeisi, Amin Saber Tanha, Atena Aghaee, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 2, 2024
Eye-Related Adverse Events After I-131 Radioiodine Therapy: A Systematic Review of the Current LiteratureElham Rahmanipour, Emran Askari, Mohammad Ghorbani, et al.
Clinical Genitourinary Cancer|January 31, 2026
Treatment Discontinuation in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Lutetium-177 (<sup>177</sup>Lu)-PSMA-617: A Retrospective Real-World StudyMohammad Hadi Samadi, Amirreza Shamshirgaran, Pegah Sahafi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|November 19, 2024
Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failuresNarjess Ayati, Emran Askari, Maryam Fotouhi, et al.
Clinical Nuclear Medicine|April 20, 2026
Exceptional Response to Short-course 177Lu-PSMA Radioligand Therapy in a Patient With Metastatic Hormone-sensitive Prostate CancerNikoo Rezaei Borujerdi, Amin Saber Tanha, Haniye Elahifard, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 13, 2023
The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid CancerFarnaz Nesari Javan, Emran Askari, Susan Shafiei, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|June 16, 2023
How did the COVID-19 pandemic affect the referral patterns for SPECT myocardial perfusion? A single center experienceSaeedeh Ataei Nakhaei, Emran Askari, Hadis Mohammadzadeh, et al.
Nuklearmedizin. Nuclear Medicine|July 10, 2024
Comparison of 8th and 7th editions of TNM staging in terms of mortality, persistent disease, and response to treatment in patients with differentiated thyroid cancerGolnaz Gholami, Atena Aghaee, Susan Shafiei, et al.
Pageof 7